TEGOPRUBART FOR THE PREVENTION OF REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: A SNAPSHOT OF EMERGING DATA FROM AN ONGOING TRIAL

WCN23-0454
Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
 
 
Kidney Transplantation and Transplant Immunology
 
 
TEGOPRUBART FOR THE PREVENTION OF REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: A SNAPSHOT OF EMERGING DATA FROM AN ONGOING TRIAL
Tchervenkov, J.(1);Harden, P.(2);Coates, P.T.(3);Kadatz, M.(4);Bornstein, J.(5)*;Gill, J.(6);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Mcgill, Surgery, Montreal, Canada;(2)Oxford, Nephrology, Oxford, United Kingdom;(3)University Of Adelaide, Medical Specialties, Adelaide, Australia;(4)Vancouver General Hospital, Nephrology, Vancouver, Canada;(5)Eledon Pharmaceuticals, Research And Deevelopment, Burlington, United States;(6)St Paul'S Hospital, Nephrology, Vancouver, Canada;
https://storage.unitedwebnetwork.com/files/1041/58c3a0ec309d1321f14e1b7ada853a2b.pdf
 
if any